These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 31463796)

  • 1. Cullin 3 overexpression inhibits lung cancer metastasis and is associated with survival of lung adenocarcinoma.
    Zhou J; Zhang S; Xu Y; Ye W; Li Z; Chen Z; He Z
    Clin Exp Metastasis; 2020 Feb; 37(1):115-124. PubMed ID: 31463796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A.
    Xu N; Liu F; Wu S; Ye M; Ge H; Zhang M; Song Y; Tong L; Zhou J; Bai C
    BMC Cancer; 2020 Mar; 20(1):262. PubMed ID: 32228507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia‑induced galectin‑3 enhances RhoA function to activate the motility of tumor cells in non‑small cell lung cancer.
    Kataoka Y; Ohshio Y; Teramoto K; Igarashi T; Asai T; Hanaoka J
    Oncol Rep; 2019 Feb; 41(2):853-862. PubMed ID: 30535445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of ubiquitin ligase Cullin3 on the proliferation, migration and invasion of triple-negative breast cancer cells and exploration of its mechanism].
    He ZX; Li J; Wang QF; Cheng Q; Ni SJ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1868-1878. PubMed ID: 38782756
    [No Abstract]   [Full Text] [Related]  

  • 6. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 7. PRDX2 Promotes the Proliferation and Metastasis of Non-Small Cell Lung Cancer
    Chen Y; Yang S; Zhou H; Su D
    Biomed Res Int; 2020; 2020():8359860. PubMed ID: 32908916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GMDS knockdown impairs cell proliferation and survival in human lung adenocarcinoma.
    Wei X; Zhang K; Qin H; Zhu J; Qin Q; Yu Y; Wang H
    BMC Cancer; 2018 May; 18(1):600. PubMed ID: 29843634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Noncoding RNA MSL3P1 Regulates CUL3 mRNA Cytoplasmic Transport and Stability and Promotes Lung Adenocarcinoma Metastasis.
    Shao MM; Li X; Wei RQ; Chen QY; Zhang X; Qiao X; Li H
    Mol Cancer Res; 2024 Aug; 22(8):746-758. PubMed ID: 38718076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of BZW1 is an independent poor prognosis marker and its down-regulation suppresses lung adenocarcinoma metastasis.
    Chiou J; Chang YC; Jan YH; Tsai HF; Yang CJ; Huang MS; Yu YL; Hsiao M
    Sci Rep; 2019 Oct; 9(1):14624. PubMed ID: 31601833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PYCR1 knockdown inhibits the proliferation, migration, and invasion by affecting JAK/STAT signaling pathway in lung adenocarcinoma.
    Gao Y; Luo L; Xie Y; Zhao Y; Yao J; Liu X
    Mol Carcinog; 2020 May; 59(5):503-511. PubMed ID: 32133692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
    Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
    Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CUL4A on the metastatic potential of lung adenocarcinoma to the bone.
    Cao PP; Chen WJ; Pang HL; Shen WW; Xue P; Duan L; Xu YX; Liu LL; Zhang HL
    Oncol Rep; 2020 Feb; 43(2):662-670. PubMed ID: 31894344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cul3 neddylation is crucial for gradual lipid droplet formation during adipogenesis.
    Dubiel D; Bintig W; Kähne T; Dubiel W; Naumann M
    Biochim Biophys Acta Mol Cell Res; 2017 Aug; 1864(8):1405-1412. PubMed ID: 28499918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NRF2 promotes breast cancer cell proliferation and metastasis by increasing RhoA/ROCK pathway signal transduction.
    Zhang C; Wang HJ; Bao QC; Wang L; Guo TK; Chen WL; Xu LL; Zhou HS; Bian JL; Yang YR; Sun HP; Xu XL; You QD
    Oncotarget; 2016 Nov; 7(45):73593-73606. PubMed ID: 27713154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cullin mediates degradation of RhoA through evolutionarily conserved BTB adaptors to control actin cytoskeleton structure and cell movement.
    Chen Y; Yang Z; Meng M; Zhao Y; Dong N; Yan H; Liu L; Ding M; Peng HB; Shao F
    Mol Cell; 2009 Sep; 35(6):841-55. PubMed ID: 19782033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic disruption of KEAP1/CUL3 E3 ubiquitin ligase complex components is a key mechanism of NF-kappaB pathway activation in lung cancer.
    Thu KL; Pikor LA; Chari R; Wilson IM; Macaulay CE; English JC; Tsao MS; Gazdar AF; Lam S; Lam WL; Lockwood WW
    J Thorac Oncol; 2011 Sep; 6(9):1521-9. PubMed ID: 21795997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZWINT is the next potential target for lung cancer therapy.
    Peng F; Li Q; Niu SQ; Shen GP; Luo Y; Chen M; Bao Y
    J Cancer Res Clin Oncol; 2019 Mar; 145(3):661-673. PubMed ID: 30643969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.